[Automatic translation follows] Support for fundraising and sale/acquisition - Valuation of startups and VSEs/SMEs - UGAP Rating Linkera is the essential solution dedicated to optimizing business acquisition and sale transactions. The platform connects business owners and potential buyers. Each month, it presents companies and assets worth millions of euros to nearly 2,000 users. Innovation, Entrepreneurship, Rating, Financial & extra-financial advice, investment, algorithm, data, UGAP, Valuation, Fundraising, Sale, Acquisitions, Financing, Startups, VSEs, and SMEs

Sectors: Consulting

Founded in 1969, Cegedim is an innovative technology and services company in the field of digital data flow management for healthcare ecosystems and B2B, and a business software publisher for healthcare and insurance professionals. Cegedim employs 6,500 people in more than 10 countries and generated revenue of €616 million in 2023. Cegedim SA is listed in Paris (EURONEXT: CGM). To learn more, please visit: www.cegedim.com And follow Cegedim on X: https://bit.ly/3HCgucL & Facebook: https://bit.ly/42i5fji & Instagram: https://bit.ly/3vWKBt7 Solutions and Services for Healthcare Companies, Solutions and Services for Healthcare Professionals, and Solutions and Services for Corporate Businesses

Sectors: IT services

[Automatic translation follows] Account of Bpifrance, the Public Investment Bank. Bpifrance, a public investment bank, supports companies from seed to stock market listing, from credit to equity. A privileged contact, Bpifrance offers financing or investment solutions in each region that are adapted to each stage of a company's life. A partner bank for entrepreneurs, Bpifrance provides them with long-term support to support their growth and competitiveness. The teams are at the heart of the regions, throughout the country, through more than 50 regional locations. Financing of SMEs, Business Creation, International Development, Investment, Creation/Transmission, Innovation, Support, Acceleration, and Export Guarantee

Sectors: Bank

[Automatic translation follows] First mutual insurance company for public service employees. #mutually Cyril, Diane, Farah, Amir, Béa... Since 1946, MGEN has been committed to all those who are committed to the interests of others. With 4.2 million people protected, 10,000 employees and 3,500 activists, MGEN is the first mutual insurance company for public service employees. Its unique model in France allows it to manage health insurance, supplementary health insurance and life insurance, whether individual or group contracts. It provides everyone with 1,700 mutual care and support structures that it co-manages and co-finances throughout France, 62 of which belong to MGEN. …

Sectors: Insurance

Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: …

Sectors: Biotechnology Startup accelerator & VC

[Automatic translation follows] PariSanté Campus, here digital health grows! PariSanté Campus aims to create a coherent and synergistic group of public and private operators, with the ambition of structuring a research and innovation sector in digital health with global influence. This group will be set up on the site of the former Val-de-Grâce military training hospital, and to create a network of partnerships in the Paris region, nationally and internationally. The group will be financed by unprecedented investments from the recovery plan, and will aim to be a major vector for the creation of medical-scientific, but also economic, value. Based …